Ying Qing

100 Kexue Road
Zhengzhou, 450001, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications

FTO degrader impairs ribosome biogenesis and protein translation in acute myeloid leukemia.

FTO degrader impairs ribosome biogenesis and protein translation in acute myeloid leukemia.

Journal: Science advances
Published: August 15, 2025

Epitranscriptomic control of cancer hallmarks: Functions, mechanisms, and therapeutics of RNA modifications.

Epitranscriptomic control of cancer hallmarks: Functions, mechanisms, and therapeutics of RNA modifications.

Journal: Cancer cell
Published: July 13, 2025

ALKBH1 Drives Tumorigenesis and Drug Resistance via tRNA-decoding Reprogramming and Codon-biased Translation.

ALKBH1 Drives Tumorigenesis and Drug Resistance via tRNA-decoding Reprogramming and Codon-biased Translation.

Journal: Cancer discovery
Published: July 19, 2024

CRISPR screening reveals ZNF217 as a vulnerability in high-risk B-cell acute lymphoblastic leukemia.

CRISPR screening reveals ZNF217 as a vulnerability in high-risk B-cell acute lymphoblastic leukemia.

Journal: Theranostics
Published: June 29, 2024

RNA Modifications in Cancer Metabolism and Tumor Microenvironment.

RNA Modifications in Cancer Metabolism and Tumor Microenvironment.

Journal: Cancer treatment and research
Published: December 19, 2023

YTHDF2 promotes ATP synthesis and immune evasion in B cell malignancies.

YTHDF2 promotes ATP synthesis and immune evasion in B cell malignancies.

Journal: Cell
Published: November 18, 2023

Metformin synergizes with gilteritinib in treating FLT3-mutated leukemia via targeting PLK1 signaling.

Metformin synergizes with gilteritinib in treating FLT3-mutated leukemia via targeting PLK1 signaling.

Journal: Cell reports. Medicine
Published: October 31, 2023

The roles and therapeutic implications of messenger RNA internal N7 -methylguanosine and N6 -methyladenosine modifications in chemoresistance.

The roles and therapeutic implications of messenger RNA internal N7 -methylguanosine and N6 -methyladenosine modifications in chemoresistance.

Journal: Clinical and translational medicine
Published: August 22, 2023

Targeting YTHDF2/MDSCs to improve radiotherapy.

Targeting YTHDF2/MDSCs to improve radiotherapy.

Journal: Cell chemical biology
Published: June 23, 2023

The roles and implications of RNA m6A modification in cancer.

The roles and implications of RNA m6A modification in cancer.

Journal: Nature reviews. Clinical oncology
Published: April 25, 2023

METTL16 promotes liver cancer stem cell self-renewal via controlling ribosome biogenesis and mRNA translation.

METTL16 promotes liver cancer stem cell self-renewal via controlling ribosome biogenesis and mRNA translation.

Journal: Journal of hematology & oncology
Published: April 19, 2023

Phosphorylation stabilized TET1 acts as an oncoprotein and therapeutic target in B cell acute lymphoblastic leukemia.

Phosphorylation stabilized TET1 acts as an oncoprotein and therapeutic target in B cell acute lymphoblastic leukemia.

Journal: Science translational medicine
Published: March 29, 2023
Showing 1-12 of 33

Last Updated: 09/26/2026